Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Anti-Obesity Prescription Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Arena Pharmaceuticals
Orexigen Therapeutics
VIVUS
Novo Nordisk
By Type:
Lorcaserin
Phentermine and Topiramate
Liraglutide
Bupropion and Naltrexone
Orlistat
By Application:
E-commerce
Retail Pharmacies
Hospitals Pharmacies
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Anti-Obesity Prescription Drugs Market Overview 2018-2029
-
1.1 China Anti-Obesity Prescription Drugs Industry Development Overview
-
1.2 China Anti-Obesity Prescription Drugs Industry Development History
-
1.3 China Anti-Obesity Prescription Drugs Industry Market Size (2018-2029)
-
1.4 China Anti-Obesity Prescription Drugs Market Analysis by Type from Production Side
-
1.4.1 China Anti-Obesity Prescription Drugs Production Volume, Production Value and Growth Rate of Lorcaserin (2018-2029)
-
1.4.2 China Anti-Obesity Prescription Drugs Production Volume, Production Value and Growth Rate of Phentermine and Topiramate (2018-2029)
-
1.4.3 China Anti-Obesity Prescription Drugs Production Volume, Production Value and Growth Rate of Liraglutide (2018-2029)
-
1.4.4 China Anti-Obesity Prescription Drugs Production Volume, Production Value and Growth Rate of Bupropion and Naltrexone (2018-2029)
-
1.4.5 China Anti-Obesity Prescription Drugs Production Volume, Production Value and Growth Rate of Orlistat (2018-2029)
-
1.5 China Anti-Obesity Prescription Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate of E-commerce (2018-2029)
-
1.5.2 China Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)
-
1.5.3 China Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate of Hospitals Pharmacies (2018-2029)
-
1.6 China Anti-Obesity Prescription Drugs Market Analysis by Region
-
1.6.1 North China Anti-Obesity Prescription Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Anti-Obesity Prescription Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Anti-Obesity Prescription Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Anti-Obesity Prescription Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Anti-Obesity Prescription Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Anti-Obesity Prescription Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Anti-Obesity Prescription Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Anti-Obesity Prescription Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Anti-Obesity Prescription Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Anti-Obesity Prescription Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Anti-Obesity Prescription Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Anti-Obesity Prescription Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Anti-Obesity Prescription Drugs Industry Development
Chapter 3 Anti-Obesity Prescription DrugsIndustry Chain Analysis
-
3.1 Anti-Obesity Prescription Drugs Industry Chain
-
3.2 Anti-Obesity Prescription Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Anti-Obesity Prescription Drugs Market
-
3.3 Anti-Obesity Prescription Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Anti-Obesity Prescription Drugs Market
Chapter 4 China Anti-Obesity Prescription Drugs Market, by Type
-
4.1 China Anti-Obesity Prescription Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Anti-Obesity Prescription Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Anti-Obesity Prescription Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Anti-Obesity Prescription Drugs Production Volume and Growth Rate of Lorcaserin
-
4.5.2 China Anti-Obesity Prescription Drugs Production Volume and Growth Rate of Phentermine and Topiramate
-
4.5.3 China Anti-Obesity Prescription Drugs Production Volume and Growth Rate of Liraglutide
-
4.5.4 China Anti-Obesity Prescription Drugs Production Volume and Growth Rate of Bupropion and Naltrexone
-
4.5.5 China Anti-Obesity Prescription Drugs Production Volume and Growth Rate of Orlistat
Chapter 5 China Anti-Obesity Prescription Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Anti-Obesity Prescription Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Anti-Obesity Prescription Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Anti-Obesity Prescription Drugs Market Size and Growth Rate of E-commerce
-
5.5.2 China Anti-Obesity Prescription Drugs Market Size and Growth Rate of Retail Pharmacies
-
5.5.3 China Anti-Obesity Prescription Drugs Market Size and Growth Rate of Hospitals Pharmacies
Chapter 6 China Anti-Obesity Prescription Drugs Market, by Region
-
6.1 China Anti-Obesity Prescription Drugs Production Volume and Production Value, by Region
-
6.2 China Anti-Obesity Prescription Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Anti-Obesity Prescription Drugs Market Analysis
-
7.1 North China Anti-Obesity Prescription Drugs Market, by Type
-
7.2 North China Anti-Obesity Prescription Drugs Market, by Application
Chapter 8 Central China Anti-Obesity Prescription Drugs Market Analysis
-
8.1 Central China Anti-Obesity Prescription Drugs Market, by Type
-
8.2 Central China Anti-Obesity Prescription Drugs Market, by Application
Chapter 9 South China Anti-Obesity Prescription Drugs Market Analysis
-
9.1 South China Anti-Obesity Prescription Drugs Market, by Type
-
9.2 South China Anti-Obesity Prescription Drugs Market, by Application
Chapter 10 East China Anti-Obesity Prescription Drugs Market Analysis
-
10.1 East China Anti-Obesity Prescription Drugs Market, by Type
-
10.2 East China Anti-Obesity Prescription Drugs Market, by Application
Chapter 11 Northeast China Anti-Obesity Prescription Drugs Market Analysis
-
11.1 Northeast China Anti-Obesity Prescription Drugs Market, by Type
-
11.2 Northeast China Anti-Obesity Prescription Drugs Market, by Application
Chapter 12 Southwest China Anti-Obesity Prescription Drugs Market Analysis
-
12.1 Southwest China Anti-Obesity Prescription Drugs Market, by Type
-
12.2 Southwest China Anti-Obesity Prescription Drugs Market, by Application
Chapter 13 Northwest China Anti-Obesity Prescription Drugs Market Analysis
-
13.1 Northwest China Anti-Obesity Prescription Drugs Market, by Type
-
13.2 Northwest China Anti-Obesity Prescription Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 Arena Pharmaceuticals
-
14.1.1 Arena Pharmaceuticals Company Profile
-
14.1.2 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Orexigen Therapeutics
-
14.2.1 Orexigen Therapeutics Company Profile
-
14.2.2 Orexigen Therapeutics Anti-Obesity Prescription Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 VIVUS
-
14.3.1 VIVUS Company Profile
-
14.3.2 VIVUS Anti-Obesity Prescription Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Novo Nordisk
-
14.4.1 Novo Nordisk Company Profile
-
14.4.2 Novo Nordisk Anti-Obesity Prescription Drugs Market Performance
-
14.4.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Anti-Obesity Prescription Drugs Industry Research Conclusions
-
15.2 Anti-Obesity Prescription Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Anti-Obesity Prescription Drugs Industry Market Size (2018-2029)
-
Figure China Anti-Obesity Prescription Drugs Production Volume, Production Value and Growth Rate of Lorcaserin (2018-2029)
-
Figure China Anti-Obesity Prescription Drugs Production Volume, Production Value and Growth Rate of Phentermine and Topiramate (2018-2029)
-
Figure China Anti-Obesity Prescription Drugs Production Volume, Production Value and Growth Rate of Liraglutide (2018-2029)
-
Figure China Anti-Obesity Prescription Drugs Production Volume, Production Value and Growth Rate of Bupropion and Naltrexone (2018-2029)
-
Figure China Anti-Obesity Prescription Drugs Production Volume, Production Value and Growth Rate of Orlistat (2018-2029)
-
Figure China Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate of E-commerce (2018-2029)
-
Figure China Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)
-
Figure China Anti-Obesity Prescription Drugs Sales Volume, Sales Value and Growth Rate of Hospitals Pharmacies (2018-2029)
-
Figure North China Anti-Obesity Prescription Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Anti-Obesity Prescription Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Anti-Obesity Prescription Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Anti-Obesity Prescription Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Anti-Obesity Prescription Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Anti-Obesity Prescription Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Anti-Obesity Prescription Drugs Market Size and Growth Rate from 2018-2029
-
Figure Anti-Obesity Prescription Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Anti-Obesity Prescription Drugs Market Share by Type in 2018
-
Figure China Anti-Obesity Prescription Drugs Market Share by Type in 2023
-
Figure China Anti-Obesity Prescription Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Anti-Obesity Prescription Drugs Production Volume and Growth Rate of Lorcaserin (2018-2023)
-
Figure China Anti-Obesity Prescription Drugs Production Volume and Growth Rate of Phentermine and Topiramate (2018-2023)
-
Figure China Anti-Obesity Prescription Drugs Production Volume and Growth Rate of Liraglutide (2018-2023)
-
Figure China Anti-Obesity Prescription Drugs Production Volume and Growth Rate of Bupropion and Naltrexone (2018-2023)
-
Figure China Anti-Obesity Prescription Drugs Production Volume and Growth Rate of Orlistat (2018-2023)
-
Figure China Anti-Obesity Prescription Drugs Market Share by Application in 2018
-
Figure China Anti-Obesity Prescription Drugs Market Share by Application in 2023
-
Figure China Anti-Obesity Prescription Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Anti-Obesity Prescription Drugs Market Size and Growth Rate of E-commerce (2018-2023)
-
Figure China Anti-Obesity Prescription Drugs Market Size and Growth Rate of Retail Pharmacies (2018-2023)
-
Figure China Anti-Obesity Prescription Drugs Market Size and Growth Rate of Hospitals Pharmacies (2018-2023)
-
Table China Anti-Obesity Prescription Drugs Production Volume by Region (2018-2023)
-
Table China Anti-Obesity Prescription Drugs Production Volume Share by Region (2018-2023)
-
Figure China Anti-Obesity Prescription Drugs Production Volume Share by Region (2018-2023)
-
Table China Anti-Obesity Prescription Drugs Production Value by Region (2018-2023)
-
Table China Anti-Obesity Prescription Drugs Production Value Share by Region (2018-2023)
-
Figure China Anti-Obesity Prescription Drugs Production Value Share by Region (2018-2023)
-
Table China Anti-Obesity Prescription Drugs Sales Volume by Region (2018-2023)
-
Table China Anti-Obesity Prescription Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Anti-Obesity Prescription Drugs Sales Volume Share by Region (2018-2023)
-
Table China Anti-Obesity Prescription Drugs Sales Value by Region (2018-2023)
-
Table China Anti-Obesity Prescription Drugs Sales Value Share by Region (2018-2023)
-
Figure China Anti-Obesity Prescription Drugs Sales Value Share by Region (2018-2023)
-
Table North China Anti-Obesity Prescription Drugs Production Volume by Type (2018-2023)
-
Table North China Anti-Obesity Prescription Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Anti-Obesity Prescription Drugs Production Volume Share by Type (2018-2023)
-
Table North China Anti-Obesity Prescription Drugs Sales Volume by Application (2018-2023)
-
Table North China Anti-Obesity Prescription Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Anti-Obesity Prescription Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Anti-Obesity Prescription Drugs Production Volume by Type (2018-2023)
-
Table Central China Anti-Obesity Prescription Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Anti-Obesity Prescription Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Anti-Obesity Prescription Drugs Sales Volume by Application (2018-2023)
-
Table Central China Anti-Obesity Prescription Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Anti-Obesity Prescription Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Anti-Obesity Prescription Drugs Production Volume by Type (2018-2023)
-
Table South China Anti-Obesity Prescription Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Anti-Obesity Prescription Drugs Production Volume Share by Type (2018-2023)
-
Table South China Anti-Obesity Prescription Drugs Sales Volume by Application (2018-2023)
-
Table South China Anti-Obesity Prescription Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Anti-Obesity Prescription Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Anti-Obesity Prescription Drugs Production Volume by Type (2018-2023)
-
Table East China Anti-Obesity Prescription Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Anti-Obesity Prescription Drugs Production Volume Share by Type (2018-2023)
-
Table East China Anti-Obesity Prescription Drugs Sales Volume by Application (2018-2023)
-
Table East China Anti-Obesity Prescription Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Anti-Obesity Prescription Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Anti-Obesity Prescription Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Anti-Obesity Prescription Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Anti-Obesity Prescription Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Anti-Obesity Prescription Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Anti-Obesity Prescription Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Anti-Obesity Prescription Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Anti-Obesity Prescription Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Anti-Obesity Prescription Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Anti-Obesity Prescription Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Anti-Obesity Prescription Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Anti-Obesity Prescription Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Anti-Obesity Prescription Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Anti-Obesity Prescription Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Anti-Obesity Prescription Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Anti-Obesity Prescription Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Anti-Obesity Prescription Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Anti-Obesity Prescription Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Anti-Obesity Prescription Drugs Sales Volume Share by Application (2018-2023)
-
Table Arena Pharmaceuticals Company Profile
-
Table Arena Pharmaceuticals Anti-Obesity Prescription Drugs Revenue, Price and Gross (2018-2023)
-
Table Orexigen Therapeutics Company Profile
-
Table Orexigen Therapeutics Anti-Obesity Prescription Drugs Revenue, Price and Gross (2018-2023)
-
Table VIVUS Company Profile
-
Table VIVUS Anti-Obesity Prescription Drugs Revenue, Price and Gross (2018-2023)
-
Table Novo Nordisk Company Profile
-
Table Novo Nordisk Anti-Obesity Prescription Drugs Revenue, Price and Gross (2018-2023)
-
